This report highlights the key figures of the GlaxoSmithKline in India and its place in the pharmaceutical market ... with an overview of its key products.

Also, they introduced the Animal health products ... Ltd into Glaxo India Limited was completed and the name of the company was changed to the present name GlaxoSmithKline Pharmaceuticals Ltd.

Global drugmaker, GlaxoSmithKline ... The company also sells several pharmaceutical products, such as vaccines and antibiotic, augmentin.

India's Intellectual Property Appellate Board (IPAB) has revoked the patent for global pharmaceutical company, GlaxoSmithKline's anti-cancer drug Tykerb. Tykerb (lapatinib) is a dual tyrosine ...

New Delhi: GlaxoSmithKline's antibiotic drug Augmentin has risen to the top slot in the Indian pharmaceutical market ... demanded covid specific products. Research firm PharmaTrac data shows ...

As the Indian Pharmaceutical Market (IPM) continues its upward trajectory, Augmentin by GlaxoSmithKline (GSK) has stood the ...

GSK Pharma board ... new state-of-the-art pharmaceutical unit in Karnataka and is looking at enhancing its global pipeline in areas like respiratory drugs and vaccines in India.

GlaxoSmithKline Pharmaceuticals Ltd. (‘GSK India’) announces completion of its transaction with Novartis Healthcare Pvt. Ltd. ... GSK Pharma's Bengaluru facility to be operational by 2017 The ...

GlaxoSmithKline Pharma India posts higher Q4 adjusted profit ... deals with Pfizer worth a combined $897 million to manufacture products for the U.S. pharmaceutical giant. Samsung Biologics ...

GlaxoSmithKline ... of the total deaths in India. MD Sridhar Venkatesh said, “As part of our parent GSK Plc’s new ambition to create two world class companies in pharmaceuticals and consumer ...

(Reuters) - India's GlaxoSmithKline Pharmaceuticals reported a higher second-quarter adjusted profit on Tuesday, driven by strong demand for its generic drugs and vaccines. The Indian unit of British ...